Why Apple's the Best Way to Invest in Chinese Growth

The following video is part of our "Motley Fool Conversations" series, in which Motley Fool senior technology analyst Eric Bleeker and chief technology officer Jeremy Phillips discuss emerging trends in technology.

In today's edition, Jeremy and Eric look at just how much greater China is contributing to Apple's sales -- $8.8 billion in the past nine months alone -- and the reasons there's still a long runway of growth left. Finally, the two look at why Apple is profiting from the market while other American tech companies have struggled to find meaningful profits in the country.

Looking for another play on mobile growth that investors in Apple can't ignore? The Motley Fool has compiled a new report called "5 Stocks The Motley Fool Owns -- And You Should Too." The report highlights a company that has licenses assuring that it profits from every 3G phone in China, a number sitting at 125 million and set to explode many times in the coming decade. Thousands have requested access to this special free report, and now you can access it today at no cost. To get instant access to the names of this company and four other great ideas click here -- it's free.

At the time thisarticle was published Both Eric Bleeker and Jeremy Phillips own shares of NVIDIA. The Motley Fool owns shares of IBM, Google, Apple, China Mobile, Intel, and Microsoft and has bought calls on Intel. Motley Fool newsletter services have recommended buying shares of Apple, Google, Intel, Baidu, China Mobile, NVIDIA, SINA, and Microsoft, creating bull call spread positions in Apple and Microsoft, creating a diagonal call position in Intel, and writing puts in NVIDIA. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.